Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.
about
Optimal approach in early breast cancer: Radiation therapySemiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer.Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.Disease Restaging and Diagnosis of Recurrent and Metastatic Disease Following Primary Therapy with FDG-PET Imaging.Novel applications of proton therapy in breast carcinoma
P2860
Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Risk of subclinical micrometas ...... s with advanced breast cancer.
@ast
Risk of subclinical micrometas ...... s with advanced breast cancer.
@en
type
label
Risk of subclinical micrometas ...... s with advanced breast cancer.
@ast
Risk of subclinical micrometas ...... s with advanced breast cancer.
@en
prefLabel
Risk of subclinical micrometas ...... s with advanced breast cancer.
@ast
Risk of subclinical micrometas ...... s with advanced breast cancer.
@en
P2093
P2860
P1476
Risk of subclinical micrometas ...... s with advanced breast cancer.
@en
P2093
Eric A Strom
Gary J Whitman
George H Perkins
Henry Yeung
Homer A Macapinlac
Isabelle Bedrosian
Jose L Cavalcanti
Julia L Oh
Thomas A Buchholz
Tse-Kuan Yu
P2860
P304
P356
10.1016/J.IJROBP.2007.10.025
P407
P577
2007-12-31T00:00:00Z